PixarBio Overview
- Year Founded
-
2014
- Status
-
Out of Business
- Employees
-
23
- Latest Deal Type
-
Out of Business
PixarBio General Information
Description
PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.
Contact Information
Website
www.pixarbio.comCorporate Office
- 8B Industrial Way
- Suite 1
- Salem, NH 03079
- United States
Corporate Office
- 8B Industrial Way
- Suite 1
- Salem, NH 03079
- United States
PixarBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 22-Sep-2022 | Completed | ||||
| 1. Reverse Merger | 30-Oct-2016 | Completed | Generating Revenue |
PixarBio Comparisons
Industry
Financing
Details
PixarBio Competitors (26)
One of PixarBio’s 26 competitors is Cytokinetics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cytokinetics | Formerly VC-backed | South San Francisco, CA | ||||
| Solid Biosciences | Formerly VC-backed | Charlestown, MA | ||||
| Passage Bio | Formerly VC-backed | Philadelphia, PA | ||||
| Taysha Gene Therapies | Formerly VC-backed | Dallas, TX | ||||
| Renova Therapeutics | Venture Capital-Backed | Carlsbad, CA |
PixarBio Patents
PixarBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2017200700-A1 | Methods for treating incisional pain | Inactive | 16-May-2016 | ||
| US-20170239183-A1 | Compositions comprising nav1.7 selective inhibitors for treating acute, post-operative, or chronic pain and methods of using the same | Inactive | 23-Feb-2016 | ||
| US-20180256502-A1 | Compositions comprising nav1.7 selective inhibitors for treating acute, post-operative, or chronic pain and methods of using the same | Inactive | 23-Feb-2016 | ||
| WO-2017147147-A1 | Compositions comprising nav1.7 selective inhibitors for treating acute, post-operative, or chronic pain and methods of using the same | Inactive | 23-Feb-2016 | ||
| AU-2016330924-A1 | Compositions for an injectable, in situ forming neuroscaffold and methods of using the same | Inactive | 02-Oct-2015 | A61L27/18 |
PixarBio Signals
PixarBio Acquisitions (1)
PixarBio’s most recent deal was a Merger/Acquisition with BMP Holdings. The deal was made on 30-Oct-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BMP Holdings | 30-Oct-2016 | Merger/Acquisition | Education and Training Services (B2B) |
PixarBio FAQs
-
When was PixarBio founded?
PixarBio was founded in 2014.
-
Where is PixarBio headquartered?
PixarBio is headquartered in Salem, NH.
-
What is the size of PixarBio?
PixarBio has 23 total employees.
-
What industry is PixarBio in?
PixarBio’s primary industry is Drug Discovery.
-
Is PixarBio a private or public company?
PixarBio is a Private company.
-
What is PixarBio’s current revenue?
The current revenue for PixarBio is .
-
Who are PixarBio’s competitors?
Cytokinetics, Solid Biosciences, Passage Bio, Taysha Gene Therapies, and Renova Therapeutics are some of the 26 competitors of PixarBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process